SECsense Logo

Context Therapeutics Inc. 8-K Report: Key Developments on January 10, 2025

$CNTX
Form 8-K
Filed on: 2025-01-13
Source
Context Therapeutics Inc. 8-K Report: Key Developments on January 10, 2025

Here are the key details extracted from the provided section of the financial report:

  1. Entity Information:
  • Name: Context Therapeutics Inc.
  • CIK: 0001842952
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-40654
  • EIN: 86-3738787
  • Address: 2001 Market Street, Suite 3915 Unit #15, Philadelphia, PA 19103
  • Phone Number: (267) 225-7416
  1. Filing Information:
  • Form Type: 8-K
  • Filing Date: January 10, 2025
  1. Stock Information:
  • Common Stock Ticker: CNTX
  • Exchange: NASDAQ
  1. Reporting Period:
  • Start Date: January 10, 2025
  • End Date: January 10, 2025

Insights:

  • The filing is an 8-K, which typically provides current reports of events that are important to shareholders. This indicates that there may be significant news or updates regarding Context Therapeutics Inc. on that date.
  • The company's incorporation in Delaware and listing on NASDAQ suggests it is a publicly traded entity subject to SEC regulations and requirements.
  • The specific filing date and the context suggest that any information disclosed may relate to immediate corporate events or developments occurring on that exact date.

This information provides a snapshot of the company's regulatory status and potential forthcoming developments that may impact investors or stakeholders in Context Therapeutics Inc.